…
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
American Healthcare REIT, Inc. is a publicly traded real estate investment trust that owns and invests in senior housing and healthcare-related properties in the United States, leasing to operators of skilled nursing, assisted living and other care facilities. Long-term growth drivers include demographic ageing, steady demand for care services, and portfolio acquisitions and lease structures that may support predictable cash flow. Investors may find the company attractive for exposure to healthcare real estate and potential income from contracted rents.
Material risks include operator credit and reimbursement pressures, regulatory and policy changes affecting Medicare/Medicaid funding, and interest-rate and leverage sensitivity that could pressure cash flows.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 48.65M | -33.89M | -76.22M | 261.64M | 179.29M |
| Minority interest | -1.01M | -2.21M | 5.42M | -7.92M | 5.47M |
| Net income | 69.81M | -37.81M | -71.47M | -72.80M | -52.31M |
| Selling general administrative | 58735.00M | 100.80M | 47.51M | 43.42M | 43.20M |
| Selling and marketing expenses | - | - | 57.48M | - | - |
| Gross profit | 39.69M | 416.77M | 293.56M | -145.91M | 81.10M |
| Reconciled depreciation | 225.20M | 221.64M | 237.30M | 200.60M | 157.38M |
| Ebit | 134.42M | 93.84M | 86.97M | -1519.37M | -1051.10M |
| Ebitda | 321.98M | 315.48M | 324.26M | 315.23M | 186.00M |
| Depreciation and amortization | 187.56M | 221.64M | 237.30M | 1834.60M | 1237.11M |
| Operating income | 167.83M | 136.78M | 244.34M | 450.47M | 133.19M |
| Other operating expenses | 2092.29M | 1933.88M | 1613.09M | 1526.91M | 1228.36M |
| Interest expense | 85.78M | 127.73M | 163.19M | 105.96M | 80.94M |
| Tax provision | -22.17M | 1.71M | 0.66M | 0.59M | 0.96M |
| Interest income | 67.17M | 124.02M | - | - | - |
| Net interest income | -85.78M | -127.73M | -163.19M | -105.96M | -80.94M |
| Income tax expense | -22.17M | 1.71M | 0.66M | -188.83M | 46.10M |
| Total revenue | 2260.12M | 2070.67M | 1859.14M | 1645.77M | 1283.21M |
| Total operating expenses | -128.14M | 279.99M | 47.51M | 185.70M | 159.44M |
| Cost of revenue | 2220.43M | 1653.89M | 1565.58M | 1791.68M | 1202.11M |
| Total other income expense net | -119.19M | -170.67M | -320.56M | -163.39M | -191.12M |
| Net income from continuing ops | 70.82M | -35.60M | -76.89M | -73.38M | -53.27M |
| Net income applicable to common shares | 69.81M | -37.81M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 5426.23M | 4488.06M | 4577.93M | 539.22M | 1062.62M |
| Intangible assets | 253.24M | 161.47M | 180.47M | 236.28M | 248.87M |
| Other current assets | - | 47.61M | -0.20M | -0.01M | 2.83M |
| Total liab | 2065.61M | 2183.89M | 3118.76M | 0.66M | 2.62M |
| Total stockholder equity | 3320.64M | 2261.23M | 1270.32M | 4786.70M | 4580.34M |
| Other current liab | - | 180.30M | 529.43M | 965.06M | 305.60M |
| Common stock | 1.85M | 1.56M | 0.66M | 0.66M | 0.66M |
| Capital stock | 1.85M | 1.56M | 0.66M | 0.66M | 0.66M |
| Retained earnings | -1559.28M | -1458.09M | -1276.22M | 1400.09M | 1581.29M |
| Good will | 234.94M | 234.94M | 234.94M | 231.61M | 209.90M |
| Other assets | 4347.90M | 3474.61M | 80.74M | -4247.47M | -3517.72M |
| Cash | 114.84M | 76.70M | 43.45M | 111.91M | 125.49M |
| Cash and equivalents | 114.84M | 76.70M | - | - | - |
| Total current liabilities | 867.50M | 946.86M | 1466.87M | 16.30M | 21.16M |
| Current deferred revenue | - | - | -565.72M | -5366.68M | -4191.51M |
| Net debt | 1473.87M | 1794.01M | 2975.68M | -47.05M | -67.95M |
| Short term debt | 0.00M | 688.53M | 846.77M | 316.73M | 921.90M |
| Short long term debt | 549.76M | 688.53M | 1223.97M | 1281.79M | 1226.63M |
| Short long term debt total | 1588.71M | 1870.71M | 3019.12M | 64.86M | 57.53M |
| Other stockholder equity | 4878.06M | 3720.27M | 2548.31M | 2540.42M | 2533.90M |
| Property plant equipment | 4318.82M | 3530.64M | - | - | - |
| Total current assets | 319.15M | 354.89M | 297.10M | 269.18M | 267.19M |
| Long term investments | 95.75M | 105.19M | 107.55M | 92.58M | 94.93M |
| Short term investments | - | - | 1.46M | - | - |
| Net receivables | 204.31M | 211.10M | 232.92M | 184.37M | 163.84M |
| Long term debt | 1000.83M | 1016.94M | 1344.15M | 1278.25M | 1129.25M |
| Inventory | 18.84M | 19.48M | 19.47M | 19.77M | 18.93M |
| Accounts payable | 317.74M | 258.32M | 90.67M | 243.83M | 187.25M |
| Accumulated other comprehensive income | -2.10M | -2.51M | -2.42M | 1649.36M | 1829.57M |
| Non currrent assets other | -4275.56M | 3467.57M | 3449.29M | -1106.00M | -979.05M |
| Non current assets total | 759.18M | 4133.16M | 4200.09M | 4517.52M | 4313.15M |
| Capital lease obligations | 135.60M | 165.24M | 225.50M | 273.07M | 145.49M |
| Long term debt total | 1550.59M | 1705.47M | - | - | - |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -8.73M | 9.40M | -118.58M | -138.65M |
| Total cashflows from investing activities | -1083.55M | -8.73M | - | - | - |
| Net borrowings | -159.94M | -995.45M | - | - | - |
| Total cash from financing activities | 817.50M | -134.74M | -129.06M | -37.74M | 102.81M |
| Net income | 70.82M | -35.60M | -71.47M | -81.30M | -47.79M |
| Change in cash | 28.45M | 32.52M | -21.12M | -13.58M | -26.70M |
| Begin period cash flow | 123.30M | 90.78M | 111.91M | 125.49M | 152.19M |
| End period cash flow | 151.75M | 123.30M | 90.78M | 111.91M | 125.49M |
| Total cash from operating activities | 294.44M | 176.09M | 98.53M | 147.77M | 15.20M |
| Issuance of capital stock | 1156.27M | 1364.26M | - | - | - |
| Depreciation | 187.56M | 221.64M | 182.60M | 450.47M | 133.19M |
| Other cashflows from investing activities | -6.61M | 83.44M | - | - | - |
| Dividends paid | 163.52M | 120.89M | 76.28M | 51.12M | 22.79M |
| Change to account receivables | -13.05M | -23.75M | -34.72M | -4.46M | 3.69M |
| Sale purchase of stock | 0.24M | -0.01M | -0.47M | -20.70M | -0.38M |
| Other cashflows from financing activities | -4.98M | -382.64M | -34.72M | -28.75M | -20.34M |
| Capital expenditures | 128.56M | 91.94M | 99.79M | 71.52M | 79.69M |
| Change in working capital | -30.32M | -68.68M | -55.79M | -37.80M | -93.47M |
| Stock based compensation | 14.62M | 9.87M | 5.47M | 3.91M | 9.66M |
| Other non cash items | 74.70M | 48.86M | 37.72M | 707.92M | 325.68M |
| Free cash flow | 165.88M | 84.15M | -1.26M | 76.25M | -64.49M |
Sector: Real Estate Industry: REIT - Healthcare Facilities
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| AHR American Healthcare REIT, Inc. |
-0.33 0.59% |
56.04 | 117.90 | 61.73 | 4.21 | 2.90 | 4.96 | 31.16 |
| WELL Welltower Inc |
-2.56 1.03% |
245.43 | 170.68 | 72.46 | 7.75 | 2.13 | 9.77 | 27.67 |
| VTR Ventas Inc |
-0.16 0.18% |
89.04 | 161.02 | 131.58 | 7.08 | 3.12 | 9.07 | 24.46 |
| OHI Omega Healthcare Investors Inc |
- -% |
47.99 | 16.83 | 10.13 | 11.78 | 2.66 | 14.30 | 12.72 |
| DOC Healthpeak Properties Inc |
-0.05 0.25% |
20.12 | 164.70 | 113.64 | 4.06 | 1.58 | 7.64 | 13.08 |
American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain compliance with REIT requirements.
18191 Von Karman Avenue, Irvine, CA, United States, 92612-7106
949 270 9200
121
| Name | Title | Year Born |
|---|---|---|
| Mr. Danny Prosky | President, CEO & Director | 1964 |
| Mr. Brian S. Peay | Chief Financial Officer | 1966 |
| Mr. Gabriel M. Willhite | Chief Operating Officer | 1982 |
| Mr. Stefan K. L. Oh | Chief Investment Officer | 1971 |
| Mr. Mark E. Foster | Executive VP, General Counsel & Secretary | 1974 |
| Mr. Kenny Lin | Executive VP, Deputy CFO & Chief Accounting Officer | 1978 |
| Mr. Alan Robert Peterson III | Vice President of Investor Relations & Finance | NA |
| Ms. Cora Lo Esq., J.D. | Senior VP, Associate General Counsel & Assistant Secretary | 1975 |
| Ms. Wendie Newman | Executive Vice President of Asset Management | 1964 |
| Mr. Ray Oborn | Executive Vice President of Asset Management | 1971 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.